Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
Roy S. Herbst, Yi-Long Lung Cancer Wu, Thomas John, Christian Grohé, Margarita Majem, Jie Wang and 19 more
- Rank
- 8 of 529
- Percentile
- top 1.6%
- Where
- Journal of Clinical Oncology, 2023
- Citations
- 413
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.